Classification and historical role
Azathioprine (Azathioprinum) is a classical immunosuppressive agent. The main objective of drugs in this pharmacological group is the artificial suppression of the patient's immune system activity.
In the history of medicine and pharmacology, this drug holds pioneer status. Historically, it was the first medication widely introduced into routine organ transplantation practice. Before its advent, foreign tissue transplantation was invariably accompanied by an aggressive immune response, but the emergence of this immunosuppressant allowed physicians to successfully control this process.
Pharmacokinetics: the prodrug pathway
A crucial feature of the drug is that it is a prodrug. In its original form, the molecule does not possess immunosuppressive properties. To become active, the substance must undergo a complex biotransformation pathway inside the body.
This process occurs in several stages:
- After entering the body, the drug is metabolized in the liver, where it is converted into its first active derivative, 6-mercaptopurine.
- Subsequently, 6-mercaptopurine undergoes further biochemical reactions and is transformed into the final working metabolite, 6-thio-GTP (guanosine triphosphate).
It is this final compound that is responsible for all subsequent pharmacological effects within the cells.
Mechanism of action: molecular blockade
The essence of the drug's action unfolds at the level of the cell's genetic material. The resulting metabolite (6-thio-GTP) structurally resembles the natural nitrogenous bases that make up nucleic acids.
As the cell prepares for division, this metabolite is incorporated into the synthesized DNA and RNA chains instead of normal bases. This incorporation leads to fatal structural defects in the molecules. These defects completely block further nucleic acid synthesis.
The logical result of this molecular blockade is a pronounced reduction in the proliferation (multiplication) of immune cells. The drug equally effectively suppresses the division of both T-lymphocytes and B-lymphocytes, depriving the immune system of its ability to mount a full-fledged response against the body's own tissues or the graft.
Indications for clinical use
The drug's ability to reliably inhibit T- and B-lymphocyte proliferation determines the spectrum of its clinical use. It is prescribed when the immune system turns against the patient's body or threatens the engraftment of donor tissues.
Key indications include:
- Transplantation: used to prevent rejection reactions during organ transplantation.
- Autoimmune diseases: suppression of the pathological immune response in rheumatoid arthritis, systemic lupus erythematosus (SLE), and ulcerative colitis (UC).
Dangerous Drug Interactions
When prescribing therapy, the physician must carefully monitor concomitant medications, as there are critically important drug interactions.
Simultaneous use with allopurinol poses a particular danger. This drug specifically inhibits the metabolism of active mercaptopurine derivatives.
Clinical consequence: Because active metabolites stop breaking down properly, a sharp enhancement and significant prolongation of azathioprine's pharmacological action occurs. There is a high risk of developing severe toxicity in the body, which requires mandatory dosage adjustments.
Briefly: answers to topical questions
For which autoimmune diseases is azathioprine indicated?
Azathioprine is used for the following autoimmune diseases and conditions of autoimmune nature:
- Rheumatoid arthritis;
- Systemic lupus erythematosus;
- Ulcerative colitis;
- Crohn's disease — including for relapse-prevention therapy after surgery or after achieving drug-induced remission;
- Autoimmune hepatitis in children — as part of combination therapy with glucocorticoids;
- Recurrent pericarditis of autoimmune origin — in the absence of an effect from colchicine and the development of steroid dependence.
Which enzyme does allopurinol block, disrupting azathioprine metabolism?
Allopurinol blocks the enzyme xanthine oxidase. Azathioprine is a prodrug that is metabolized in the liver into active 6-mercaptopurine. Normally, this metabolite is inactivated precisely by xanthine oxidase. When taken concurrently, allopurinol inhibits this enzyme, which slows down the metabolism of active derivatives. As a result, the action of azathioprine is enhanced and prolonged, and its toxicity increases sharply, primarily causing bone marrow suppression.
What specific side effects does azathioprine cause?
The use of azathioprine carries the risk of developing a number of severe side effects. Specific complications of therapy include:
- Bone marrow suppression — manifesting as leukopenia and other cytopenias;
- Hepatotoxicity — the risk of toxic hepatitis;
- Infectious complications — increased susceptibility to bacterial, viral, and fungal infections;
- Secondary oncogenicity — increased risk of developing lymphoma and leukemia;
- Teratogenic effect — impairment of embryonic development.
What are the absolute contraindications to azathioprine?
Contraindications to the use of azathioprine are pregnancy and lactation.
Azathioprine is like a «typo» in the genetic text. The metabolite (6-thio-GTP) is incorporated into the DNA/RNA chain instead of the correct letter, making further reading (nucleic acid synthesis) impossible, and the cell cannot divide.
Class and exam questions
Does the drug affect immunity immediately after administration?
No, because it is a prodrug. First, it must be metabolized in the liver to 6-mercaptopurine and then converted into active 6-thio-GTP. Only after this does the suppression of immune reactions begin.
How exactly does the drug stop lymphocyte division?
Its active metabolite is incorporated into DNA and RNA chains instead of normal bases. This causes structural defects that block further nucleic acid synthesis, and the cell loses its ability to proliferate.
Which cells of the immune system are the main target?
The drug causes a non-selective reduction in proliferation. It suppresses the multiplication of T-lymphocytes and B-lymphocytes with equal effectiveness.
Why is it dangerous to prescribe allopurinol to patients taking this immunosuppressant?
Allopurinol inhibits the metabolism of active mercaptopurine derivatives. This leads to an uncontrolled enhancement and prolongation of the immunosuppressant's action, which dramatically increases the risk of severe toxicity.
What else to study on this topic
- Biochemical stages of the conversion of 6-mercaptopurine to 6-thio-GTP.
- The role of T- and B-lymphocytes in the pathogenesis of systemic lupus erythematosus (SLE) and rheumatoid arthritis.
- Immunological mechanisms of organ rejection in transplantation.
- Toxic effects arising from the excessive accumulation of mercaptopurine derivatives.
- Differences between prodrugs and direct-acting drugs in clinical pharmacology.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on «Azathioprine» and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Analgesics" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.